WINDTREE THERAPEUTICS INC /DE/ Treasury Stock, Common, Value
WINDTREE THERAPEUTICS INC /DE/ (WINT) had Treasury Stock, Common, Value of $3.05 million as of 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:TreasuryStockCommonValue · last filed 2025-11-19
- 2025-09-30: Treasury Stock, Common, Value $3.05M.
- 2025-06-30: Treasury Stock, Common, Value $3.05M.
- 2025-03-31: Treasury Stock, Common, Value $3.05M.
- 2024-12-31: Treasury Stock, Common, Value $3.05M.
| Period end | Treasury Stock, Common, Value |
|---|---|
| 2025-09-30 | $3.05M 10-Q · filed 2025-11-19 |
| 2025-06-30 | $3.05M 10-Q · filed 2025-08-19 |
| 2025-03-31 | $3.05M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $3.05M 10-Q · filed 2025-11-19 |
| 2024-09-30 | $3.05M 10-Q · filed 2024-11-26 |
| 2024-06-30 | $3.05M 10-Q · filed 2024-08-19 |
| 2024-03-31 | $3.05M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $3.05M 10-K · filed 2025-04-15 |
| 2023-09-30 | $3.05M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $3.05M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $3.05M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $3.05M 10-K · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |